The Thrombinator system is designed to produce autologous serum at the point of care. This autologous serum helps improve the handling of graft tissue hydrated with platelet-rich plasma or bone marrow aspirate by activating the clotting cascade to produce a gel that serves as a binding agent for graft tissue material. The Thrombinator process applies the principles of the clotting cascade to produce autologous serum without the use of harsh chemical reagents.
-
Filter by Language
-
Filter by Date of Update
-
Sort By
-
Brochures (1)
-
- File Type:
- Ref. #: vLB1-000439-en-US
- Version: A
- Language: English
- Revision Date: 07/07/2023
-
-
White Papers (2)
-
- File Type:
- Ref. #: vLA1-000165-en-US
- Version: A
- Language: English
- Revision Date: 12/08/2022
-
- File Type:
- Ref. #: LA1-000156-en-US
- Version: A
- Language: English
- Revision Date: 08/18/2022
-
-
Customer Service
- 1370 Creekside Boulevard
- Naples, FL 34108
- United States
- Phone: +1-800-934-4404
- Fax: +1-800-643-9310
-
Latex Information
Arthrex, Inc. products are designed without any latex components or packaging. The primary packaging has been selected to not include latex in any form. If you have any further questions in this regard please contact your Customer Service Representative and they will assist you as promptly as possible.
Thrombinator™ System